Differences in PD-L1 expression on tumor and immune cells between lung metastases and corresponding primary tumors

There were significant differences in PD-L1 expression on TCs and ICs between lung metastases and primary tumors. Clinicians should be aware of these differences in the tumor microenvironment when treating patients with immunotherapy.